Cargando…
Profound systemic alteration of the immune phenotype and an immunoglobulin switch in Erdheim-Chester disease in 78 patients from a single center
Erdheim-Chester disease (ECD) is a rare, systemic, non-Langerhans cell histiocytosis neoplasm, which is characterized by the infiltration of CD63(+) CD1a(-) histiocytes in multiple tissues. The BRAF(V600E) mutation is frequently present in individuals with ECD and has been detected in hematopoietic...
Autores principales: | Aubart, Fleur Cohen, Poupel, Lucie, Saint-Charles, Flora, Charlotte, Frédéric, Arsafi, Youssef, Frisdal, Eric, Roos-Weil, Damien, Emile, Jean-François, Amoura, Zahir, Guerin, Maryse, Lesnik, Philippe, Haroche, Julien, Le Goff, Wilfried |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152974/ https://www.ncbi.nlm.nih.gov/pubmed/34647443 http://dx.doi.org/10.3324/haematol.2021.279118 |
Ejemplares similares
-
Psychiatric disorders, personality and neuropsychological alterations in Erdheim-Chester disease
por: Soumet-Leman, Charlotte, et al.
Publicado: (2023) -
PD-1/PD-L1 expression is frequent and correlated with lymphocyte density in Erdheim-Chester disease
por: Charlotte, Fréderic, et al.
Publicado: (2022) -
Cardiac involvement resolution is frequent and associated with improved outcome in Erdheim-Chester disease
por: Azoulay, Lévi-Dan, et al.
Publicado: (2023) -
Erdheim-Chester disease: look it in the eye. An orbital magnetic resonance imaging study
por: Haroche, Julien, et al.
Publicado: (2022) -
Serum vascular endothelial growth factor is associated with cardiovascular involvement and response to therapy in Erdheim-Chester disease
por: Roeser, Anaïs, et al.
Publicado: (2022)